Jean-Yves Masson
Chercheur universitaire
Axe Oncologie
Dernières nouvelles
Voir tout
Publications
Voir tout-
article Richardson ME, Bishop MFH, Holdren MA, de la Hoya M, Spurdle AB, Tavtigian SV, Brannan T, Young CC, Zec L, Hiraki S, Turnbull C, Tischkowitz M, Bernstein KA, Masson JY, McNulty SM, Pesaran T, Monteiro AN, Walker LC, Foulkes WD, Couch FJ
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants
Am J Hum Genet 113 (5), 2026.
-
article Le BV, Vekariya U, Toma MM, Nieborowska-Skorska M, Caron MC, Gozdecka M, Haydar Z, Walsh M, Ghosh J, Vaughan-Williams E, Podszywalow-Bartnicka P, Kukuyan AM, Ziolkowska S, Atkins J, Hadzijusufovic E, Chandramouly G, Nejati R, Piwocka K, Pomerantz R, Vassiliou GS, Huntly BJP, Valent P, Wasik M, Bellacosa A, Masson JY, Gupta GP, Challen GA, Skorski T
Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemia
Cell Rep Med 7 (3), 2026.
-
article Cui S, Batenburg NL, Coulombe Y, Arumugam A, Walker JR, Sheida SV, Bielinsky AK, Wahl MC, Masson JY, Zhu XD
Ski2-like helicase ASCC3 unwinds DNA upon fork stalling to control replication stress responses
Cell Rep 45 (3), 2026.
Projets
- Emerging roles of Zinc Finger PAR-Interacting Proteins (ZIPPs) in DNA double-strand break (DSB) repair: implications in PARPi therapy, du 2024-04-01 au 2029-03-31
- Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays., du 2024-04-01 au 2029-03-31
- Caractérisation de nouveaux gènes de susceptibilité au cancer du sein, du 2024-02-15 au 2027-03-31
- Roles of the tumor suppressor PALB2 at the intersection of DNA repair and synthetic lethal strategies in cancer, du 2024-10-01 au 2029-09-30
- Defining and targeting the eraser functions of Poly(ADP-ribose) Glycohydrolase (PARG) in PAR-DNA hybrids and DNA double-strand break repair, du 2025-07-01 au 2030-06-30
- Assays evaluating small molecule RAD51 inhibitors: the road to anti-RAD51 drugs to treat aggressive and drug-resistant breast cancer, du 2024-06-30 au 2026-12-31
- Defining the biological consequences of formaldehyde-induced DNA lesions, du 2025-04-01 au 2030-03-31
- Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays, du 2025-04-01 au 2029-03-31
- Label-free analysis of biomolecular interactions with next-gen biolayer interferometry, du 2026-03-31 au 2027-03-31
- MOHCCN Centre Transition Award, du 2026-04-01 au 2026-09-30
- Réseau de recherche sur le cancer (RRCancer), du 2023-04-01 au 2026-03-31
- Tumor biobanking was supported by the Banque de tissus et de données en cancers solides of the Réseau de recherche sur le cancer (RRCancer)...The RRCancer is funded by the Oncopole...de l'Économie, de l'Innovation et de l'Énergie du Québec., du 2023-04-01 au 2026-03-31
- Unveiling the roles of Poly(ADP)ribose Glycohydrolase (PARG) in DNA repair and cancer, du 2024-09-01 au 2025-08-31